Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients

被引：0
作者：
Rumyana Ivanova Dodova
Atanaska Velichkova Mitkova
Daniela Rosenova Dacheva
Lina Basam Hadjo
Alexandrina Ivanova Vlahova
Margarita Stoyanova Taushanova - Hadjieva
Spartak Stoyanov Valev
Marija Mitko Caulevska
Stanislava Dimitrova Popova
Ivan Emilov Popov
Tihomir Iliichev Dikov
Theophil Angelov Sedloev
Atanas Stefanov Ionkov
Konstanta Velinova Timcheva
Svetlana Liubomirova Christova
Ivo Marinov Kremensky
Vanio Ivanov Mitev
Radka Petrova Kaneva
机构：
[1] Medical University of Sofia,Molecular Medicine Center
[2] Medical University of Sofia,Department of Medical Chemistry and Biochemistry, Medical Faculty
[3] University Hospital “Alexandrovska”,General and Clinical Pathology Clinic
[4] Medical University of Sofia,Department of General and Clinical Pathology
[5] Clinic of Medical Oncology (Chemotherapy),Department of Surgery
[6] Specialized Hospital for Active Treatment in Oncology,Department of General and Liver
[7] University Hospital “Tsaritsa Yoana - ISUL”,Pancreatic Surgery
[8] Medical Faculty,Medical Faculty
[9] University Hospital “Alexandrovska”,undefined
[10] Medical University of Sofia,undefined
来源：
BMC Cancer | / 15卷
关键词：
Breast cancer; Genetic testing; Mutations; Sequencing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 186 条
[1]  
Miki Y(1994)A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66-71
[2]  
Swensen J(1995)Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789-792
[3]  
Shattuck-Eidens D(2013)Hereditary breast and ovarian cancer susceptibility genes (Review) Oncol Rep 30 1019-1029
[4]  
Futreal PA(2011)BRCA in breast cancer: ESMO clinical practice guidelines Ann Oncol Suppl 6 vi31-vi4
[5]  
Harshman K(2003)Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected incase series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117-30
[6]  
Tavtigian S(2013)Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers Br J Cancer 108 2172-2177
[7]  
Wooster R(2013)EMBRACE. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE J Natl Cancer Inst 105 812-22
[8]  
Bignell G(1995)Inherited breast and ovarian cancer Hum Mol Genet 4 1811-1817
[9]  
Lancaster J(2006)Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JAMA 295 1379-88
[10]  
Swift S(2011)BRCA1 and BRCA2 mutations and breast cancer Discov Med 12 445-453
12345678910